EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic and metabolomic profiling reveals the underlying molecular mechanisms in modified alternate-day fasting-mediated protection against Diabetic kidney disease

Xin Zeng, Yi-Hang Xing, Xiu-Mei Ma, Yang Long, Zong-Zhe Jiang, Yong Xu iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0319053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Xin Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Proteomics, Fasting, Metabolomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of China, Sichuan Science and Technology Program, Luzhou Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic kidney disease (DKD) is a leading cause of chronic kidney disease, and while lifestyle interventions like intermittent fasting have shown promise in treating diabetes, the impact of modified alternate-day fasting (MADF) on DKD is not well understood. This study aimed to explore MADF’s effects on DKD in db/db mice, a model for the condition, and to investigate its underlying mechanisms.

Methods

We implemented an MADF regimen in db/db mice on a high-fat diet, measuring blood glucose, body weight, and renal function at various times. After the intervention, we analyzed the proteome and metabolome of renal tissues.

Results

MADF was found to reduce hyperglycemia and slow the pathological progression of DKD in the mice. Proteomic analysis identified 165 proteins that increased and 196 that decreased in the kidneys of db/db mice compared to controls. MADF intervention led to a decrease in 26 of the increased proteins and an increase in 18 of the decreased ones. Notably, many of these proteins, including cathepsin S (CTSS), were related to lysosomes, suggesting a role in renal protection. Metabolomic profiling revealed changes in metabolites associated with inflammation, such as prostaglandin A1, which was downregulated in db/db mice and upregulated with MADF. Western blotting, immunohistochemistry, and immunofluorescence staining confirmed the expression changes of CTSS observed in the proteomic data. Additionally, CTSS expression was found to increase in renal cells exposed to high glucose and palmitic acid.

Conclusion

MADF appears to mitigate the progression of DKD, with proteomic evidence pointing to lysosome-related proteins like CTSS as potential mediators of its renal protective effects. These findings indicate that MADF and the inhibition of CTSS could be considered as novel therapeutic strategies for DKD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesProteomicsFastingMetabolomicsMetabolomeProteomeAnimalsMiceMaleKidneyDiet, High-FatMice, Inbred C57BLBlood Glucose

Substanzen

ProteomeBlood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
  • Sichuan Provincial Key Laboratory for Human Disease Gene Study and Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Metabolic Vascular Disease Key Laboratory of Sichuan Province, Sichuan, People's Republic of China.
  • Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, People's Republic of China.

ORCID-Profile: Yong Xu

Förderung

  • the Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Luzhou Science and Technology Program

Zitieren

APA

Zeng, X., Xing, Y. H., Ma, X. M., Long, Y., Jiang, Z. Z., & Xu, Y. (2025). Proteomic and metabolomic profiling reveals the underlying molecular mechanisms in modified alternate-day fasting-mediated protection against Diabetic kidney disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0319053

Vancouver

Zeng X, Xing YH, Ma XM, Long Y, Jiang ZZ, Xu Y. Proteomic and metabolomic profiling reveals the underlying molecular mechanisms in modified alternate-day fasting-mediated protection against Diabetic kidney disease. PLOS ONE. 2025. doi:10.1371/journal.pone.0319053

BibTeX
@article{Zeng2025,
  author = {Zeng, Xin and Xing, Yi-Hang and Ma, Xiu-Mei and Long, Yang and Jiang, Zong-Zhe and Xu, Yong},
  title = {Proteomic and metabolomic profiling reveals the underlying molecular mechanisms in modified alternate-day fasting-mediated protection against Diabetic kidney disease},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0319053}
}
Kostenlos starten →